The outcomes of Perthes' disease of the hip: a study protocol for the development of a core outcome set

被引:9
|
作者
Leo, Donato Giuseppe [1 ]
Leong, Wei Yee [2 ]
Gambling, Tina [3 ]
Long, Andrew [4 ]
Murphy, Rebecca [1 ]
Jones, Helen [1 ]
Perry, Daniel Christopher [5 ]
机构
[1] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England
[2] Alder Hey Childrens Hosp, Prescott Rd, Liverpool L14 2AB, Merseyside, England
[3] Cardiff Univ, Sch Healthcare Sci, Cardiff, S Glam, Wales
[4] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England
[5] Univ Liverpool, Inst Translat Med, Inst Pk,Prescott Rd, Liverpool L14 2AB, Merseyside, England
关键词
Core outcomes set; Delphi; Consensus outcomes; Perthes' disease; Legg-calve-Perthes' disease;
D O I
10.1186/s13063-018-2695-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Perthes' disease is an idiopathic osteonecrosis of a developmental hip that is most frequent in Northern Europe. Currently, the absence of a common set of standardised outcomes makes comparisons between studies of different interventions challenging. This study aims to summarise the outcomes used in clinical research of interventions for Perthes' disease and define a set of core outcomes (COS) to ensure that the variables of primary importance are measured and reported in future research studies investigating Perthes' disease. Methods: A systematic review of the current literature will be used to identify a list of outcomes reported in previous studies. Additional important outcomes will be sought by interviewing a group of children with Perthes' disease, adults who were treated with the disease in infancy and parents of children with the disease. This list will then be evaluated by experts in Perthes' disease using a Delphi survey divided into two rounds to ascertain the importance of each outcome. The final outcomes list obtained from the Delphi survey will be then discussed during a consensus meeting of representative key stakeholders in order to define the COS to be reported in future clinical trials related to Perthes' disease. Discussion: The absence of high-quality research and clear guidelines concerning the management of Perthes' disease is, at least in part, due to the difficulties in the comparing the results from previous studies. The development of a COS seeks to standardise outcomes collected in future research studies to enable comparisons between studies to be made and to facilitate meta-analyses of results.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Ma, Christopher
    Panaccione, Remo
    Fedorak, Richard N.
    Parker, Claire E.
    Khanna, Reena
    Levesque, Barrett G.
    Sandborn, William J.
    Feagan, Brian G.
    Jairath, Vipul
    BMJ OPEN, 2017, 7 (06):
  • [32] Pregnancy Nutrition Core Outcome Set (PRENCOS): A core outcome set development study
    Killeen, Sarah Louise
    Callaghan, Shauna L.
    O'Reilly, Sharleen L.
    McAuliffe, Fionnuala M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 (10) : 1247 - 1257
  • [33] Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set
    Nicola L. Harman
    John Wilding
    Dave Curry
    James Harris
    Jennifer Logue
    R. John Pemberton
    Leigh Perreault
    Gareth Thompson
    Sean Tunis
    Paula R. Williamson
    Trials, 19
  • [34] Relationships and Sex Education Outcomes for Students With Intellectual Disability: Protocol for the Development of a Core Outcome Set
    Paulauskaite, Laura
    Totsika, Vasiliki
    Rivas, Carol
    JMIR RESEARCH PROTOCOLS, 2022, 11 (11):
  • [35] Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set
    Harman, Nicola L.
    Wilding, John
    Curry, Dave
    Harris, James
    Logue, Jennifer
    Pemberton, R. John
    Perreault, Leigh
    Thompson, Gareth
    Tunis, Sean
    Williamson, Paula R.
    TRIALS, 2018, 19
  • [36] Development of a Core Outcome Set for Dysphagia Interventions in Parkinson's disease (COS-DIP): study protocol
    Hirschwald, Julia
    Duncan, Sallyanne
    Warnecke, Tobias
    Boyle, Gary
    Regan, Julie
    Walshe, Margaret
    BMJ OPEN, 2024, 14 (02):
  • [37] Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol
    Sheng, Xiaodi
    Chen, Chao
    Ji, Zhaochen
    Hu, Haiyin
    Zhang, Mingyan
    Wang, Hui
    Pang, Bo
    Zhai, Jingbo
    Zhang, Dong
    Zhang, Junhua
    Guo, Liping
    BMJ OPEN, 2022, 12 (11):
  • [38] Protocol for the development of a core outcome set for neonatal sepsis (NESCOS)
    Taneri, Petek Eylul
    Kirkham, Jamie J.
    Molloy, Eleanor J.
    Biesty, Linda
    Polin, Richard A.
    Wynn, James L.
    Stoll, Barbara J.
    Kissoon, Niranjan
    Kawaza, Kondwani
    Daly, Mandy
    Branagan, Aoife
    Bonnard, Livia Nagy
    Giannoni, Eric
    Strunk, Tobias
    Ohaja, Magdalena
    Mugabe, Kenneth
    Suguitani, Denise
    Quirke, Fiona
    Devane, Declan
    PLOS ONE, 2023, 18 (12):
  • [39] Protocol for development of a core outcome set for clinical trials in melasma
    Ibrahim, Sarah A.
    Kang, Bianca Y.
    Schlessinger, Daniel, I
    Chiren, Sarah G.
    Tang, Jennifer C.
    Kirkham, Jamie J.
    Schmitt, Jochen
    Poon, Emily
    Maher, Ian A.
    Sobanko, Joseph F.
    Cartee, Todd, V
    Alam, Murad
    BMJ OPEN, 2022, 12 (02):
  • [40] Protocol for development of a core outcome set for menopausal symptoms (COMMA)
    Kim, Bobae, V
    Iliodromiti, Stamatina
    Christmas, Monica
    Bell, Robin
    Lensen, Sarah
    Hickey, Martha
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1371 - 1375